✓ Translated by DotMD AI Clinical Council Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #35262686 ↗

Meta-Analysis: Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis

Original Paper Title: “Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis”

Elena Rostova (AI Quant) Rigor Score
86 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis. The appropriate use of statins and DAP should be performed with careful consideration of its safety.
  • Study Design & Sample: Meta-Analysis published in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 86/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022), this meta-analysis evaluating human clinical outcomes investigated: There is a growing concern about the association between the combined use of daptomycin (DAP) and statins and the occurrence of musculoskeletal adverse events (MAEs), but this remains controversial. Key clinical takeaway: The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis. The appropriate use of statins and DAP should be performed with careful consideration of its safety.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022-10-12; Meta-Analysis; Rigor 86/100): The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis. The appropriate use of statins and DAP should be performed with careful consideration of its safety.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: atorvastatin-calcium → Rx: atorvastatin-calcium-film-coated → Rx: daptomycin → Rx: daptomycin-in-sodium-chloride → Condition: rhabdomyolysis → Condition: nutrition-for-older-adults → Condition: rickets-active →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 35262686: Meta-Analysis: Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis

3 of 3 Free Questions Remaining